Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $2.35 Million - $4.63 Million
37,000 Added 77.89%
84,500 $5.65 Million
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $2.86 Million - $4.72 Million
-28,300 Reduced 37.34%
47,500 $5.64 Million
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $281,721 - $380,952
3,300 Added 4.55%
75,800 $8.08 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $1.74 Million - $2.61 Million
25,000 Added 52.63%
72,500 $7.21 Million
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $8.39 Million - $11 Million
-87,000 Reduced 64.68%
47,500 $4.91 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $8.64 Million - $11.7 Million
72,900 Added 118.34%
134,500 $16.3 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $5.98 Million - $8.69 Million
44,100 Added 252.0%
61,600 $9.46 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $12.6 Million - $22.4 Million
-106,700 Reduced 85.91%
17,500 $3.14 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $4.85 Million - $7.98 Million
-41,100 Reduced 24.86%
124,200 $14.7 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $12.2 Million - $18.4 Million
104,000 Added 169.66%
165,300 $23.6 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $7.36 Million - $13.7 Million
58,200 Added 1877.42%
61,300 $10.6 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $2.69 Million - $4.39 Million
-11,900 Reduced 79.33%
3,100 $787,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $532,560 - $1.16 Million
2,400 Added 19.05%
15,000 $5.77 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $1.14 Million - $2.07 Million
8,800 Added 231.58%
12,600 $2.96 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $249,811 - $645,468
3,800 New
3,800 $397,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.